(Press-News.org) JUPITER, FL, November 19, 2010 – Scientists from the Florida campus of The Scripps Research Institute have identified a novel synthetic activator of a pair of proteins that belong to a protein family playing key roles in human metabolism and immune function. The discovery could provide new and potentially more effective therapeutic approaches to diseases ranging from diabetes to osteoporosis.
The study was published in the November issue (Volume 5, Issue 11) of the journal ACS Chemical Biology.
"This new compound is particularly important because it works in vivo, and it is selective for certain receptors," said Tom Burris, a professor in the Department of Molecular Therapeutics at Scripps Florida who led the study. "These two properties give it significant potential as a possible therapeutic compound."
The new discovery represents the very first synthetic ligand (binding partner) that functions as an agonist (activator) of retinoid-related orphan (ROR) nuclear receptor. Nuclear receptors are protein molecules that mediate hormone activity inside the cell; they have been implicated in the progress of a number of cancers, and have also become drug development targets for diseases including type 2 diabetes, atherosclerosis, and metabolic syndrome.
Although scientists don't know the full therapeutic significance of the new synthetic ligand, its potential usefulness is clear, Burris noted.
"For example, loss of RORα in animal models renders them resistant to weight gain," he said, "while RORγ has been shown to be involved in development of cells that are implicated in autoimmune diseases – and loss of RORγ results in animals that are resistant to these types of disease."
RORα has also been shown to be required for normal bone development; animal models lacking this receptor develop osteoporosis, strongly suggesting that RORα agonists may have potential as a treatment of this disease. Osteoporosis affects as many as 44 million Americans, according to the National Institutes of Health. Burris and his colleagues also discovered a pathway stimulating liver secretion of FGF21—which has been shown to treat diabetic animals—via activation of ROR. Diabetes is estimated to affect 23.6 million Americans, according to the National Institutes of Health.
Second Major Discovery
This new agonist is the second that Burris and his Scripps Florida colleagues have identified.
In 2009, Burris and Patrick R. Griffin, chair of the Department of Molecular Therapeutics and director of the Translational Research Institute at Scripps Florida, identified a high affinity synthetic inverse agonist of this same pair of nuclear receptors. An inverse agonist, which binds to the same site as an agonist, induces the opposite action of an agonist of that receptor.
For this new study, Burris said they used that first discovery, a compound known as T1317, as a molecular scaffold to synthesize an array of compounds and assess their activity against a number of receptors, including RORα and RORγ.
The one compound that stood out was SR1078, which displayed a unique pharmacological profile that indicated it had a high potential for use as a chemical probe for assessing ROR receptor function in general.
"Unexpectedly, we found that SR1078 functioned as a ROR agonist," Burris said. "When we treated cells with SR1078 we got a significant increase in RORα transcription. Similarly, with RORγ, SR1078 treatment resulted in a stimulation of RORγ dependent transcription activity. Basically, it produced more of these receptor proteins, significantly so."
INFORMATION:
The first author of the study, "Identification of SR1078, a Synthetic Agonist for the Orphan Nuclear Receptors RORα and RORγ," is Yongjun Wang of Scripps Research. Others authors include Naresh Kumar, Philippe Nuhant, Michael D. Cameron, Monica A. Istrate, William R. Roush, and Patrick R. Griffin, also of Scripps Research. For more information on the study, see http://pubs.acs.org/doi/abs/10.1021/cb1002575
The study was supported by the National Institutes of Health.
About The Scripps Research Institute
The Scripps Research Institute is one of the world's largest independent, non-profit biomedical research organizations, at the forefront of basic biomedical science that seeks to comprehend the most fundamental processes of life. Scripps Research is internationally recognized for its discoveries in immunology, molecular and cellular biology, chemistry, neurosciences, autoimmune, cardiovascular, and infectious diseases, and synthetic vaccine development. An institution that evolved from the Scripps Metabolic Clinic founded by philanthropist Ellen Browning Scripps in 1924, Scripps Research currently employs approximately 3,000 scientists, postdoctoral fellows, scientific and other technicians, doctoral degree graduate students, and administrative and technical support personnel. Headquartered in La Jolla, California, the institute also includes Scripps Florida, whose researchers focus on basic biomedical science, drug discovery, and technology development. Scripps Florida is located in Jupiter, Florida. For more information, see www.scripps.edu
FORT COLLINS - In the last 50 years, modern medicine has made astounding advances in surgery, yet many of today's veterinary and human medicine students still hone basic surgical and suturing skills on carpet pads and pig's feet before transitioning to a live patient. An invention by Colorado State University veterinarians provides students with artificial body parts that look, feel, behave, and even bleed just like real skin, muscles and vessels.
The artificial replicas of sections of human and animal bodies -- such as an abdominal wall -- give students a realistic learning ...
HOUSTON, Nov. 19, 2010 – University of Houston (UH) physicists are using complex computer simulations to illuminate the workings of a crucial protein that, when malfunctioning, may cause Alzheimer's and cancer.
Margaret Cheung, assistant professor of physics at UH, and Antonios Samiotakis, a physics Ph.D. student, described their findings in a paper titled "Structure, function, and folding of phosphoglycerate kinase (PGK) are strongly perturbed by macromolecular crowding," published in a recent issue of the journal Proceedings of the National Academy of Sciences, one ...
Researchers in the United States have developed a medical model for regenerating bladders using stem cells harvested from a patient's own bone marrow. The research, published in STEM CELLS, is especially relevant for paediatric patients suffering from abnormally developed bladders, but also represents another step towards new organ replacement therapies.
The research, led by Dr Arun Sharma and Earl Cheng from the Feinberg School of Medicine at Northwestern University and Children's Memorial Research Center, focused on bone marrow mesenchymal stem cells (MSCs) taken from ...
CORVALLIS, Ore. – The first study to ever explore biological activity in the deepest layer of ocean crust has found bacteria with a remarkable range of capabilities, including eating hydrocarbons and natural gas, and "fixing" or storing carbon.
The research, just published in the journal PLoS One, showed that a significant number and amount of bacterial forms were present, even in temperatures near the boiling point of water.
"This is a new ecosystem that almost no one has ever explored," said Martin Fisk, a professor in the College of Oceanic and Atmospheric Sciences ...
COLLEGE STATION - Functional amino acids play a critical role in the development of both animals and humans, according to a Texas AgriLife Research scientist.
In a journal article appearing in the American Society for Nutrition (Advances in Nutrition 1:31-37, 2010), Dr. Guoyao Wu, AgriLife Research animal nutritionist and senior faculty fellow in the department of animal science at Texas A&M University, calls for scientists to "think out of the box" and place more emphasis on this area of study.
"We need to move forward and capitalize on the potential of functional ...
Though it's been at least a billion years since plants and animals shared a common ancestor, they have through the eons shared a common threat in the form of microbes, including bacteria, eukaryotes and viruses. This has resulted in remarkably similar mechanisms for detecting the molecular signatures of infectious organisms that hold promise for the future treatment of infectious diseases in humans.
The recognition of microbial signature molecules by host receptors is the subject of a paper published in the journal Science titled "Plant and Animal Sensors of Conserved ...
1. Kidney Disease Patients Benefit from a Diet High in Fruits and Vegetables
Healthy Foods Can Help Maintain Kidney Function
In patients with kidney disease, the Western diet produces an acidic environment in the body that has numerous negative effects and worsens with age as kidney function declines. Nimirit Goraya, MD (Texas A&M College of Medicine and Scott and White Healthcare) and her colleagues conducted a study to see if consuming a diet high in fruits and vegetables that counteract this acidity might improve the kidney health of 40 patients who have moderately ...
Gap Adventures founder Bruce Poon Tip announced today the appointment of ecotourism industry veteran Megan Epler Wood as Director of Planeterra (http://www.planeterra.org), the global non-profit dedicated to sustainable community development through travel and voluntourism. Epler Wood will share duties with newly named Associate Director Paula Vlamings.
"I have known Megan for many years and have such deep respect for her and for her commitment and leadership in defining and building on her vision for sustainable travel," says Poon Tip. "She is the best person on Earth ...
We have seen big changes at SESG over the past few months. Meet the new team!
Strathclyde University and Associates: Dr Jeremy Cockroft took over as director of SESG at the beginning of April 2006. He is supported by Dr Jon Hand and Dr Aizaz Samuel. We have a vacancy that we hope to fill soon. Here is a brief resume of the people now in the group: Jon has had experience as a practicing architect specializing in low energy buildings and alternative construction techniques. He is a simulation consultant in several continents, a software developer, and a mentor to companies ...
The staff and friends of The Old Schoolhouse Magazine (TOS) have come together to share their favorite family traditions, recipes, and more by offering the 2010 Digital Holiday Supplement magazine.
Gena Suarez, publisher of The Old Schoolhouse Magazine, states: "If you're looking for inspiration to get your holiday spirit revived for the upcoming season of festivities, you've come to the right place. TOS has put together a gorgeous, full-color, digital magazine filled to the virtual brim with traditions-in-the-making.
This is TOS's gift to the homeschooling community, ...
